BSD Medical's Premier Cancer Treatment System Can Now Treat Children's Cancers

SALT LAKE CITY, July 31, 2008 (PRIME NEWSWIRE) -- BSD Medical Corporation
(Nasdaq:BSDM) today announced that the company's most advanced cancer treatment
system, the BSD-2000/3D/MR, has been adapted to treat children with cancer, as
well as adults. To accommodate the treatment of children, BSD Medical has
developed sophisticated treatment applicators that are specifically sized for
small and medium-sized children, and that are capable of delivering pediatric
cancer therapy during simultaneous magnetic resonance imaging (MRI) of the
treatment in progress. The BSD-2000/3D/MR was developed as a combined effort
between BSD Medical Corp. and Siemens Medical Systems. Initial targets for
treatment of children's cancers include germ cell tumors and soft tissue
sarcomas.

BSD Medical is currently shipping a Sigma 40/MR pediatric applicator that has
been purchased by Erlangen University Medical School in Germany. This new
applicator will upgrade the university's BSD-2000/3D/MR system to allow for its
use in treating children's cancers as well as adult cancers. The Sigma 40/MR was
developed by BSD Medical and has the same patent protection as do all of BSD's
Sigma applicators.

The Erlangen University Medical School is a prestigious cancer treatment center
that has a long-standing tradition of offering world-class cancer care in
Germany, including the use of BSD Medical's systems. Erlangen University
Hospital is at the forefront of international medical research and also plays an
integral part in patient care in the Bavarian region of Germany.

BSD Medical Corp. is the leading developer of systems used to deliver
precision-focused microwave/RF energy to diseased sites in the body, including
cancer. Its treatments are used to kill cancer directly and increase the
effectiveness of companion radiation treatments for certain tumors. For further
information visit BSD Medical's website at www.BSDMedical.com.

Statements contained in this press release that are not historical facts are
forward-looking statements, as defined in the Private Securities Litigation
Reform Act of 1995. All forward-looking statements are subject to risks and
uncertainties detailed in the Company's filings with the Securities and Exchange
Commission. These forward-looking statements speak only as of the date on which
such statements are made, and the Company undertakes no obligation to update
such statements to reflect events or circumstances arising after such date.

-0-
CONTACT: BSD Medical Corporation
Hyrum A. Mead
(801) 972-5555
Fax: (801) 972-5930
investor@bsdmc.com